Low-Density Lipoprotein Receptor-Related Protein 8 at the Crossroad between Cancer and Neurodegeneration
Related Experiment Video
Updated: Aug 30, 2025

Monitoring Leucine-Rich Repeat Containing 8 Channel (LRRC8/VRAC) Activity Using Sensitized-Emission Förster Resonance Energy Transfer (SE-FRET)
Published on: August 9, 2024
Daniela Passarella1, Silvia Ciampi1, Valentina Di Liberto2
1Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.
Abstract:
The low-density-lipoprotein receptors represent a family of pleiotropic cell surface receptors involved in lipid homeostasis, cell migration, proliferation and differentiation. The family shares common structural features but also has significant differences mainly due to tissue-specific interactors and to peculiar proteolytic processing. Among the receptors in the family, recent studies place low-density lipoprotein receptor-related protein 8 (LRP8) at the center of both neurodegenerative and cancer-related pathways. From one side, its overexpression has been highlighted in many types of cancer including breast, gastric, prostate, lung and melanoma; from the other side, LRP8 has a potential role in neurodegeneration as apolipoprotein E (ApoE) and reelin receptor, which are, respectively, the major risk factor for developing Alzheimer's disease (AD) and the main driver of neuronal migration, and as a γ-secretase substrate, the main enzyme responsible for amyloid formation in AD. The present review analyzes the contributions of LDL receptors, specifically of LRP8, in both cancer and neurodegeneration, pointing out that depending on various interactions and peculiar processing, the receptor can contribute to both proliferative and neurodegenerative processes.
Insights
Low-density lipoprotein receptor-related protein 8 (LRP8) plays a dual role in cell proliferation and neurodegeneration. Its function depends on specific interactions and processing, impacting cancer and Alzheimer
Area of Science:
- Molecular Biology
- Cell Biology
- Neuroscience
- Oncology
Background:
- Low-density lipoprotein receptors (LDLRs) are cell surface proteins crucial for lipid homeostasis, cell migration, proliferation, and differentiation.
- The LDLR family exhibits structural similarities but significant functional differences due to tissue-specific interactions and proteolytic processing.
- Low-density lipoprotein receptor-related protein 8 (LRP8) is increasingly recognized for its involvement in both cancer and neurodegenerative diseases.
Purpose of the Study:
- To review the multifaceted roles of LDLRs, with a specific focus on LRP8, in the context of cancer and neurodegeneration.
- To elucidate how LRP8's interactions and processing influence its contribution to proliferative and neurodegenerative processes.
Main Methods:
- Literature review of recent studies on LDLR family members, particularly LRP8.
- Analysis of LRP8's involvement in cancer pathways through overexpression data.
- Examination of LRP8's role in neurodegeneration via its interactions with apolipoprotein E (ApoE), reelin, and its function as a γ-secretase substrate.
Main Results:
- LRP8 overexpression is observed in various cancers, including breast, gastric, prostate, lung, and melanoma, suggesting a role in cancer progression.
- LRP8 acts as a receptor for apolipoprotein E (ApoE), a major risk factor for Alzheimer's disease (AD).
- LRP8 is implicated in neuronal migration (via reelin) and is a substrate for γ-secretase, an enzyme central to amyloid formation in AD.
Conclusions:
- LRP8 exhibits pleiotropic functions, acting as a critical mediator in both cancer development and neurodegenerative processes like AD.
- The specific biological outcome (proliferative or neurodegenerative) is contingent upon LRP8's unique interactions and proteolytic processing.
- Understanding LRP8's dual role offers potential therapeutic targets for both cancer and Alzheimer's disease.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Neural Regulation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

